Lin, H., Jeng, W., Liu, J., Pan, M., Lee, M., Batrla‐Utermann, R., . . . Chen, C. (2024). Persistently high HBsAg levels during HBeAg‐seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary pharmacology & therapeutics, 59(8), 993-1002. https://doi.org/10.1111/apt.17915
Chicago Style (17th ed.) CitationLin, Hsin‐Che, et al. "Persistently High HBsAg Levels During HBeAg‐seropositive Stage Predict Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients." Alimentary Pharmacology & Therapeutics 59, no. 8 (2024): 993-1002. https://doi.org/10.1111/apt.17915.
MLA (9th ed.) CitationLin, Hsin‐Che, et al. "Persistently High HBsAg Levels During HBeAg‐seropositive Stage Predict Lower Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients." Alimentary Pharmacology & Therapeutics, vol. 59, no. 8, 2024, pp. 993-1002, https://doi.org/10.1111/apt.17915.